Latest Health It Market News

Singular Health has submitted a 510(k) premarket notification to the FDA for its enhanced 3DICOM MD Cloud platform, aiming to expand imaging capabilities and introduce a scalable, cloud-native solution for medical image management.

RLF AgTech reports a robust 34% increase in Australian revenue for the four months to October 2025, driven by stronger distributor engagement and promising trial results. The company is poised for growth as it enters its critical January–June 2026 sales season with an expanded national footprint.

Resonance Health reports positive cash flow and significant progress in its clinical trials and Software-as-a-Medical Device business, setting the stage for growth in new international markets.

Medibank has set ambitious goals to triple its health segment earnings by FY30, expand its private health insurance market share, and double its health engagement, signaling a strategic pivot towards integrated, technology-driven care.

Salter Brothers Emerging Companies Limited has announced a further 12-month extension of its on-market share buy-back program, allowing the company to repurchase up to 8.45 million shares to maintain capital management flexibility and enhance shareholder value.

Hydrix Limited will have its trading suspension lifted on 13 October 2025 following the release of its audited financial statements for FY2025. Investors await clarity on the company’s financial health as it returns to the ASX.

EDU Holdings Limited is set to renew its on-market share buyback program, aiming to repurchase up to 14.4 million shares over the next year, continuing its strategy to enhance shareholder value.

TasFoods has agreed to sell its Pyengana Dairy business for $2 million, aiming to reduce debt and refocus on its poultry supply chain. The sale awaits shareholder approval with settlement expected by early November.

LTR Pharma has acquired a one-third equity stake in LevOmega Pty Ltd at no cost to shareholders, positioning itself in the growing pharmaceutical-grade omega-3 sector. This strategic move complements LTR’s existing intranasal pharmaceutical portfolio and aligns with its innovation-driven growth strategy.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

Pro-Pac Packaging is progressing a strategic review involving potential asset sales and liquidity support, with ASX trading suspension imminent pending financial disclosures.

MCS Security Services Limited reported a 63% revenue decline following the sale of its Security Business, yet improved its net loss and underlying EBITDA in FY25. The Traffic Business showed promising growth, while the company weighs capital management and potential divestments.